InvestorsHub Logo
Followers 1
Posts 150
Boards Moderated 0
Alias Born 03/22/2009

Re: sts66 post# 73480

Sunday, 02/28/2016 3:56:43 PM

Sunday, February 28, 2016 3:56:43 PM

Post# of 426522
Fwiw, I have no problem whatsoever with JL. I come here to others' opinion and he has plenty to offer. But it doesn't mean that I agree with everything he or anyone else says. For example, he believes that the drug will sell itself after Reduce-It since we are in the internet age. Supporting that belief was the experience of Agouron Pharmaceuticals which was the maker of Viracept, a protease inhibitor that became a very successful-viral in the attack on the AIDS epidemic. The drug needed very little marketing because they were dealing with a very intelligent, very motivated audience. I don't believe the task will be as simple with Vascepa..... even with Reduce it.

But I'm happy to have JL, HDG, and many others on the board. I have worked with many PHDs, and even more finance guys and find them both very informative
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News